Quadrant Capital Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,279
| Closed | -$235K | – | 2741 |
|
|
2021
Q2 | $235K | Sell |
1,279
-36
| -3% | -$6.18K | 0.03% | 342 |
|
|
2021
Q1 | $201K | Buy |
1,315
+627
| +91% | +$97K | 0.03% | 354 |
|
|
2020
Q4 | $107K | Sell |
688
-62
| -8% | -$7.97K | 0.02% | 478 |
|
|
2020
Q3 | $86K | Buy |
750
+282
| +60% | +$30.4K | 0.02% | 477 |
|
|
2020
Q2 | $53K | Buy |
468
+129
| +38% | +$13.7K | 0.01% | 698 |
|
|
2020
Q1 | $33K | Sell |
339
-474
| -58% | -$46.5K | 0.01% | 1078 |
|
|
2019
Q4 | $82K | Buy |
813
+583
| +253% | +$62.4K | 0.01% | 1089 |
|
|
2019
Q3 | $18K | Sell |
230
-29
| -11% | -$3.27K | ﹤0.01% | 1626 |
|
|
2019
Q2 | $28K | Sell |
259
-631
| -71% | -$81.3K | ﹤0.01% | 1500 |
|
|
2019
Q1 | $115K | Buy |
890
+725
| +439% | +$90.2K | 0.02% | 736 |
|
|
2018
Q4 | $11K | Sell |
165
-52
| -24% | -$6.15K | ﹤0.01% | 1371 |
|
|
2018
Q3 | $26K | Sell |
217
-11
| -5% | -$1.38K | 0.01% | 880 |
|
|
2018
Q2 | $22K | Buy |
228
+7
| +3% | +$818 | 0.01% | 944 |
|
|
2018
Q1 | $19K | Buy |
221
+76
| +52% | +$9.08K | 0.01% | 982 |
|
|
2017
Q4 | $14K | Sell |
145
-15
| -9% | -$1.83K | 0.01% | 1061 |
|
|
2017
Q3 | $18K | Buy |
160
+51
| +47% | +$6.93K | 0.01% | 955 |
|
|
2017
Q2 | $10K | Sell |
109
-163
| -60% | -$19K | ﹤0.01% | 1122 |
|
|
2017
Q1 | $28K | Buy |
272
+75
| +38% | +$9.67K | 0.01% | 740 |
|
|
2016
Q4 | $20K | Buy |
197
+64
| +48% | +$7.83K | 0.01% | 763 |
|
|
2016
Q3 | $13K | Buy |
133
+73
| +122% | +$9.4K | 0.01% | 959 |
|
|
2016
Q2 | $3K | Sell |
60
-213
| -78% | -$30.2K | ﹤0.01% | 1384 |
|
|
2016
Q1 | $33K | Buy |
273
+90
| +49% | +$13.2K | 0.02% | 517 |
|
|
2015
Q4 | $30K | Sell |
183
-551
| -75% | -$96.3K | 0.02% | 476 |
|
|
2015
Q3 | $113K | Buy |
734
+2
| +0.3% | +$365 | 0.08% | 219 |
|
|
2015
Q2 | $130K | Buy |
+732
| New | +$126K | 0.08% | 202 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM